Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/8453
Title: Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines.
Authors: Peña, Alexia S
Curran, Jacqueline A
Fuery, Michelle
George, Catherine
Jefferies, Craig A
Lobley, Kristine
Ludwig, Karissa
Maguire, Ann M
Papadimos, Emily
Peters, Aimee
Sellars, Fiona
Speight, Jane
Titmuss, Angela
Wilson, Dyanne
Wong, Jencia
Worth, Caroline
Dahiya, Rachana
Citation: © 2020 AMPCo Pty Ltd.
Med J Aust. 2020 Jun 23. doi: 10.5694/mja2.50666.
Abstract: INTRODUCTION: The incidence of type 2 diabetes mellitus has increased in children and adolescents due largely to the obesity epidemic, particularly in high risk ethnic groups. β-Cell function declines faster and diabetes complications develop earlier in paediatric type 2 diabetes compared with adult-onset type 2 diabetes. There are no consensus guidelines in Australasia for assessment and management of type 2 diabetes in paediatric populations and health professionals have had to refer to adult guidelines. Recent international paediatric guidelines did not address adaptations to care for patients from Indigenous backgrounds. MAIN RECOMMENDATIONS: This guideline provides advice on paediatric type 2 diabetes in relation to screening, diagnosis, diabetes education, monitoring including targets, multicomponent healthy lifestyle, pharmacotherapy, assessment and management of complications and comorbidities, and transition. There is also a dedicated section on considerations of care for children and adolescents from Indigenous background in Australia and New Zealand. CHANGES IN MANAGEMENT AS A RESULT OF THE GUIDELINES: Published international guidelines currently exist, but the challenges and specifics to care for children and adolescents with type 2 diabetes which should apply to Australasia have not been addressed to date. These include: recommendations regarding care of children and adolescents from Indigenous backgrounds in Australia and New Zealand including screening and management; tighter diabetes targets (glycated haemoglobin, ≤ 48 mmol/mol [≤ 6.5%]) for all children and adolescents; considering the use of newer medications approved for adults with type 2 diabetes under the guidance of a paediatric endocrinologist; and the need to transition adolescents with type 2 diabetes to a diabetes multidisciplinary care team including an adult endocrinologist for their ongoing care.
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/32578226
Journal title: The Medical journal of Australia
Publication Date: 2020/06/23
Type: Journal Article
URI: https://hdl.handle.net/10137/8453
DOI: 10.5694/mja2.50666
metadata.dc.identifier.orcid: 0000-0002-1204-6896
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.